Short communication Long-term persistence of nonpathogenic clonal chromosome abnormalities in donor hematopoietic cells after allogeneic stem cell transplantation

We describe the cases of two unrelated patients who exhibited multiple chromosomal abnormalities in donor cells after allogeneic peripheral blood stem cell transplantation (PBSCT). The patients were diagnosed with chronic myeloid leukemia and chronic lymphocytic leukemia, respectively, and both underwent nonmyeloablative conditioning with cyclophosphamide and fludarabine fol- lowed by PBSCT from their HLA-matched opposite-sex siblings. Post-transplant bone marrow cytogenetics showed full engraftment, and the early post-transplant studies demonstrated only normal donor metaphases. Subsequent studies of both patients, however, revealed a population of metaphase cells with abnormal, but apparently balanced, donor karyotypes. Chromosome studies performed on peripheral blood cells collected from both donors after transplantation were normal. Both patients remained in clinical remission during follow-up of approximately 8 years in one case, and 6 years in the other case, despite the persistence of the abnormal clones. Chromosomal abnor- malities in residual recipient cells after bone marrow or PBSCT are not unusual. In contrast, only rare reports of chromosome abnormalities in donor cells exist, all of which have been associated with post-bone marrow transplant myelodysplastic syndrome or acute leukemias. The present cases demonstrate the rare phenomenon of persistent clonal nonpathogenic chromosome aberrations in

[1]  S. Kamel‐Reid,et al.  Inv (11)(p15q21) in donor‐derived Ph‐negative cells in a patient with chronic myeloid leukemia in relapse successfully treated with imatinib mesylate post allogeneic stemcell transplantation , 2007, American journal of hematology.

[2]  K. Foucar,et al.  Acute myeloid leukemia of donor origin after allogeneic bone marrow transplantation for precursor T‐cell acute lymphoblastic leukemia: Case report and review of the literature , 2006, American journal of hematology.

[3]  H. Kantarjian,et al.  Sudden blastic transformation in patients with chronic myeloid leukemia treated with imatinib mesylate. , 2006, Blood.

[4]  R. Srinivasan,et al.  Treatment of relapsed blast-phase Philadelphia-chromosome-positive leukaemia after non-myeloablative stem-cell transplantation with donor lymphocytes and imatinib. , 2005, The Lancet. Oncology.

[5]  Y. Aizawa,et al.  Persistence of various chromosomal aberrations in recipient cells during complete remission after bone marrow transplantation followed by graft rejection. , 2005, Leukemia research.

[6]  K. Reddy,et al.  Translocation (X;20)(q13;q13.3): a nonrandom abnormality in four patients with myeloid disorders. , 2005, Cancer genetics and cytogenetics.

[7]  D. Ben‐Yehuda,et al.  Therapy-related Leukemia and Myelodysplasia: Evolving Concepts of Pathogenesis and Treatment , 2004, Hematology.

[8]  E. Bayever,et al.  Chromosomal transformation in donor cells following allogeneic bone marrow transplantation , 2004, Bone Marrow Transplantation.

[9]  M. Deininger,et al.  Clonal Cytogenetic Abnormalities in Philadelphia Chromosome Negative Cells in Chronic Myeloid Leukemia Patients Treated with Imatinib , 2004, Leukemia & lymphoma.

[10]  M. Sever,et al.  Genotoxic potential of cyclosporin A in patients with renal transplantation , 1999, Cell Biology and Toxicology.

[11]  G. Dölken,et al.  Chromosomal translocation t(14;18) in healthy individuals. , 2003, Seminars in cancer biology.

[12]  Judit Müller,et al.  Donor-cell myelodysplastic syndrome developing 13 years after marrow grafting for aplastic anemia. , 2003, Cancer genetics and cytogenetics.

[13]  Lois Shepherd,et al.  Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  M. Lawler,et al.  Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia , 2002, Bone Marrow Transplantation.

[15]  T. Ahmed,et al.  Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapy , 2001, Leukemia.

[16]  W. Harrison,et al.  Donor cell leukemia: Report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature , 2000, American journal of hematology.

[17]  J. Vardiman,et al.  Increased incidence of second neoplasms in patients treated with interferon alpha 2b for hairy cell leukemia: a clinicopathologic assessment. , 1994, Blood.

[18]  L. Kearney,et al.  Leukaemia arising in donor cells following allogeneic bone marrow transplantation for β thalassaemia demonstrated by immunological, DNA and molecular cytogenetic analysis , 1993, British journal of haematology.

[19]  A. Bacigalupo,et al.  Recurrence of Philadelphia chromosome-positive leukemia in donor cells after bone marrow transplantation for chronic granulocytic leukemia. , 1993, Leukemia & lymphoma.

[20]  F. Behm,et al.  Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. , 1991, The New England journal of medicine.

[21]  L. Robison,et al.  Second neoplasms after acute lymphoblastic leukemia in childhood. , 1991, The New England journal of medicine.

[22]  B. Dutrillaux,et al.  Chromosomal aberrations in lymphocytes of patients treated with melphalan , 1989, International journal of cancer.

[23]  I. Kondo,et al.  Mutagenicity of cyclosporine. Induction of sister chromatid exchange in human cells. , 1986, Transplantation.

[24]  F. Frassoni,et al.  Recurrence of Ph'-positive leukemia in donor cells after marrow transplantation for chronic granulocytic leukemia. , 1984, The New England journal of medicine.

[25]  K. Goh,et al.  In vivo leukemic transformation: Cytogenetic evidence of in vivo leukemic transformation of engrafted marrow cells , 1977, American journal of hematology.